Segall Bryant & Hamill, LLC Jazz Pharmaceuticals PLC Transaction History

Segall Bryant & Hamill, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $285,207 - $353,540	-2,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $7,192 - $8,740	-60 Reduced 2.65%	2,200 $280,000
Q3 2021 Nov 03, 2021	SELL	$128.64 - $184.79 $4,502 - $6,467	-35 Reduced 1.53%	2,260 $294,000
Q2 2021 Aug 12, 2021	SELL	$160.2 - $186.42 $961 - $1,118	-6 Reduced 0.26%	2,295 $407,000
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $901 - $1,041	6 Added 0.26%	2,301 $378,000
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $6,277 - $7,223	-50 Reduced 2.13%	2,295 $0
Q2 2018 Aug 08, 2018	BUY	$146.33 - $183.18 $343,143 - $429,557	2,345 New	2,345 $0

544

59M

125K

58.4K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.79B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.